13F-HR filed by EcoR1 Capital, LLC
EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-15, with 51 holding rows worth $957,232,000.
- Accession
- 0001567619-20-010491
- Filer
- CIK 1587114
- Filed
- 2020-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2020
A holdings report, 51 entries on the cover page, a total value of $957,232,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $957,232,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTHENA CORP PLC SHS | G72800108 | Stock | 9,426,640 | $100,865,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 2,501,557 | $74,747,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 1,528,031 | $61,580,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 3,346,301 | $61,472,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,341,875 | $52,013,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 4,393,236 | $44,328,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 3,036,014 | $42,899,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 3,693,203 | $42,029,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 2,823,141 | $41,444,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 2,590,680 | $38,420,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 3,511,690 | $34,941,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 882,138 | $30,654,000 | thousands by filing date | |
| INNATE PHARMA S A | 45781K204 | SPONSORED ADS | 4,465,668 | $29,831,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 357,849 | $27,508,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 2,248,306 | $27,407,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 2,536,156 | $21,405,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 1,715,962 | $20,763,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 1,106,180 | $18,307,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 371,208 | $16,493,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 2,308,079 | $14,702,000 | thousands by filing date | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 653,981 | $13,858,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 323,889 | $13,684,000 | thousands by filing date | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 698,101 | $12,224,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,249,611 | $11,546,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 4,597,701 | $11,080,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 208,609 | $9,863,000 | thousands by filing date | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 270,418 | $9,267,000 | thousands by filing date | |
| ZIOPHARM ONCOLOGY INC | 98973P101 | COM | 3,750,000 | $9,188,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 3,255,813 | $8,595,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 2,248,300 | $8,544,000 | thousands by filing date | |
| CYCLERION THERAPEUTICS INC | 23255M105 | COM | 2,742,276 | $7,267,000 | thousands by filing date | |
| CHIASMA INC | 16706W102 | COM | 1,512,627 | $5,521,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 350,000 | $5,145,000 | thousands by filing date | |
| EXICURE INC | 30205M101 | COM | 2,841,301 | $4,205,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 292,100 | $4,054,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 1,432,664 | $3,037,000 | thousands by filing date | |
| LIFESCI ACQUISITION CORP | 53228P208 | UNIT 03/31/2025 | 300,000 | $3,000,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 1,274,463 | $2,383,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,087,312 | $2,171,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 737,612 | $1,556,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 41,407 | $1,469,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 30,510 | $1,294,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 94,819 | $1,274,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 291,997 | $1,180,000 | thousands by filing date | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 50,809 | $1,034,000 | thousands by filing date | |
| REGULUS THERAPEUTICS INC | 75915K200 | COM NEW | 1,886,812 | $870,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 13,946 | $816,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 264,166 | $602,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 256,075 | $581,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 6,269 | $108,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 1,101 | $8,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-20-010491 | this filing | 2020-05-15 | acceptance time not in the bulk data set |